Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exagen

7.27
+0.05000.69%
Post-market: 7.270.00000.00%19:26 EDT
Volume:95.65K
Turnover:693.33K
Market Cap:158.93M
PE:-8.61
High:7.39
Open:7.30
Low:7.16
Close:7.22
Loading ...

Exagen Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
25 Jul

Exagen Initiated at Buy by Craig-Hallum

Dow Jones
·
24 Jul

BRIEF-Exagen Appoints Chas Mckhann To Board Of Directors

Reuters
·
18 Jul

Exagen Appoints Chas McKhann to Board of Directors

TIPRANKS
·
18 Jul

Exagen Inc. Appoints Chas McKhann to Board of Directors, Aiming to Drive Strategic Growth

Reuters
·
18 Jul

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

GlobeNewswire
·
16 Jul

Press Release: Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

Dow Jones
·
23 Jun

Exagen Registers 1.15 Million Share Sale by Investor Perceptive Credit Holdings

MT Newswires Live
·
21 Jun

BRIEF-Exagen files prospectus related to resale of up to 1.2 mln shares

Reuters
·
21 Jun

Exagen files to sell 1.15M shares of common stock for holders

TIPRANKS
·
21 Jun

Exagen Inc. Holds 2025 Annual Stockholder Meeting

TIPRANKS
·
12 Jun

Exagen Inc. Concluded Annual Stockholders Meeting with Four Proposals Voted

Reuters
·
12 Jun

Exagen Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
15 May

Exagen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
13 May

Exagen Enters Underwriting Agreement for Stock Offering

TIPRANKS
·
09 May

BUZZ-U.S. STOCKS ON THE MOVE-Tapestry, Carvana, PPG Industries

Reuters
·
08 May

Exagen Prices $17.6 Million Public Offering; Shares Down

MT Newswires Live
·
08 May

BRIEF-Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share

Reuters
·
08 May

BUZZ-Exagen falls after stock sale launch

Reuters
·
08 May

Exagen Inc. Announces Public Offering of Common Stock to Expand Autoimmune Testing Solutions

Reuters
·
08 May